Search Results

You are looking at 1 - 2 of 2 items for

  • Author or Editor: P. D. Schwarz x
  • Refine by Access: All Content x
Clear All Modify Search

Abstract

Objective—To evaluate owners' perceptions of the outcomes of dogs that have undergone total hip arthroplasty (THA).

Design—Survey.

Sample Population—Owners of 145 dogs that had undergone THA.

Procedure—Surveys were mailed to owners of 353 dogs that underwent THA between 1982 and 1996. Owners were asked to answer multiple-choice questions and provide written comments.

Results—The response rate was 41%. For owners who responded to the survey, time from surgery to completion of the questionnaire ranged from 6 months to 11 years. Overall, 122 respondents (84.1%) rated results of THA in their dog as excellent or good.

Conclusion and Clinical Relevance—Results suggest that owners are generally satisfied with the results of THA in their dogs. (J Am Vet Med Assoc 2000;217:1010–1012)

Full access
in Journal of the American Veterinary Medical Association

Objective

To assess the efficacy of etodolac in improving hind limb function in dogs with osteoarthritis of the hip joint.

Design

Prospective study.

Animals

100 client-owned dogs with clinical signs of osteoarthritis of the hip joint.

Procedure

Baseline ground reaction forces and subjective assessment scores were collected twice at a 7- to 10-day interval. After meeting entrance criteria, dogs were randomly assigned to the following 3 treatment groups: control group (0 mg of etodolac), low-dosage group (135 mg of etodolac), or high-dosage group (450 mg of etodolac). Dogs were treated once daily for 8 days, and gait analysis was repeated on day 8.

Results

On day 8 of treatment, vertical impulse and vertical peak force values for low- and high-dosage groups were significantly greater than baseline values within each group. On day 8, vertical impulse values from the high-dosage group were significantly greater than values from the low-dosage group. Vertical peak forces for the low- and high-dosage groups were significantly greater at 8 days than that of the control group. Analysis of the effect of evaluation center (site) on treatment outcome did not reveal a significant effect.

Clinical Implications

Etodolac administration for 8 days improved ground reaction forces in dogs with osteoarthritis of the hip joint. Improvement in force transmission was dosage dependent for the primary outcome measurement (vertical impulse). Results of the study indicate that etodolac is well tolerated by dogs, with minimal adverse effects during an 8-day treatment period. (J Am Vet Med Assoc 1999;214:206–210)

Free access
in Journal of the American Veterinary Medical Association